Namrata Saroj sold $232K of OCUL stock

Namrata Saroj, Chief Business Officer of Ocular Therapeutix, Inc (OCUL), sold 35,370 shares of OCUL stock worth $232K, per an SEC Form 4 filed Nov 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 5, 2026, 4 days before it was made public.

OCUL has moved +6.5% since the trade date, from $6.43 to $6.85 (Nov 9, 2026 close).